Overview Of Value Stocks In The Healthcare Sector

Understanding Value Stocks

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

1. Valneva VALN - P/E: 6.41
2. Humacyte HUMA - P/E: 0.92
3. Chimerix CMRX - P/E: 0.7
4. Retractable Technologies RVP - P/E: 2.01
5. Maravai LifeSciences MRVI - P/E: 8.78

This quarter, Valneva experienced an increase in earnings per share, which was $-2.86 in Q2 and is now $1.33. This quarter, Humacyte experienced a decrease in earnings per share, which was $-0.19 in Q2 and is now $-0.25. Most recently, Chimerix reported earnings per share at $-0.24, whereas in Q3 earnings per share sat at $2.75. Retractable Technologies has reported Q3 earnings per share at $0.16, which has increased by 245.45% compared to Q2, which was -0.11. Most recently, the company reported a dividend yield of 13.16%, which has decreased by 0.1% from last quarter's yield of 13.26%.

Most recently, Maravai LifeSciences reported earnings per share at $0.35, whereas in Q3 earnings per share sat at $0.37.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.